Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis

Annals of the New York Academy of Sciences

Volumn 1414, Issue 1, 2018, Pages 31-46

  Blencowe, Hannah ^a   Kancherla, Vijaya ^b   Moorthie, Sowmiya ^c   Darlison, Matthew W ^d   Modell, Bernadette ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b EMORY UNIVERSITY   (United States)

^c PHG FOUNDATION   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

estimates; mortality; neural tube defects; prevalence; spina bifida

Indexed keywords

ANENCEPHALUS; ARTICLE; CHILDHOOD MORTALITY; COMPARTMENT MODEL; ENCEPHALOCELE; FETUS MALFORMATION; HEALTH CARE ACCESS; HUMAN; LIVE BIRTH; META ANALYSIS; NEURAL TUBE DEFECT; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREVALENCE; SPINAL DYSRAPHISM; STILLBIRTH; SYSTEMATIC REVIEW;

EID: 85040996426     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.13548     Document Type: Article

References (55)

1. Botto, L.D., C.A. Moore, M.J. Khoury, et al. 1999. Neural-tube defects. N. Engl. J. Med. 341: 1509–1519
2. Blencowe, H., S. Cousens, B. Modell, et al. 2010. Folic acid to reduce neonatal mortality from neural tube disorders. Int. J. Epidemiol. 39(Suppl. 1): i110–i121
3. De-Regil, L.M., J.P. Pena-Rosas, A.C. Fernandez-Gaxiola, et al. 2015. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst. Rev. CD007950
4. Castillo-Lancellotti, C., J.A. Tur & R. Uauy. 2013. Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutr. 16: 901–911
5. Sims-Williams, H.J., H.P. Sims-Williams, E. Mbabazi Kabachelor, et al. 2017. Quality of life among children with spina bifida in Uganda. Arch. Dis. Child. 102: 1057–1061
6. Bakaniene, I., A. Prasauskiene & N. Vaiciene-Magistris. 2016. Health-related quality of life in children with myelomeningocele: a systematic review of the literature. Child Care Health Dev. 42: 625–643
7. Oakeshott, P., F. Reid, A. Poulton, et al. 2015. Neurological level at birth predicts survival to the mid-40s and urological deaths in open spina bifida: a complete prospective cohort study. Dev. Med. Child Neurol. 57: 634–638
8. Moorthie, S. et al. 2017. An overview of concepts and approaches used in estimating the burden of congenital disorders globally. J. Community Genet. https://doi.org/10.1007/s12687-017-0335-3
9. Modell, B., M.W. Darlinson, S. Moorthie, et al. 2016. Epidemiological methods in community genetics and the Modell Global Database of Congenital Disorders (MGDb). Accessed October 12, 2017. http://discovery.ucl.ac.uk/1532179/
10. Christianson, A., C.P. Howson & C.B. Modell. 2006. March of Dimes global report on birth defects: the hidden toll of dying and disabled children. Birth Defects Foundation, White Plains, New York. Accessed November 2, 2017. https://www.marchofdimes.org/global-report-on-birth-defects-the-hidden-toll-of-dying-and-disabled-children-full-report.pdf
11. European Surveillance of Congenital Anomalies (EUROCAT). Accessed October 12, 2017. http://www.eurocat-network.eu/
12. International Clearing House for Birth Defects. Accessed October 12, 2017. http://www.icbdsr.org/
13. Estudio Colaborativo Latino Americano de Malformaciones Congénitas (ECLAMC). Accessed October 12, 2017. http://www.eclamc.org/
14. National Birth Defects Prevention Network. Accessed October 12, 2017. https://www.nbdpn.org/
15. South-East Asia Region New-Born and Birth Defects (SEAR-NBBD) Surveillance Initiative. 2017. SEAR-NBBD (newborn and birth defects database). Accessed October 12, 2017. http://www.searo.who.int/entity/child_adolescent/en/
16. Williams, J., C.T. Mai, J. Mulinare, et al. 2015. Updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011. MMWR Morb. Mortal. Wkly. Rep. 64: 1–5
17. Yadav, U., P. Kumar, S.K. Yadav, et al. 2015. “Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis”. Metab. Brain Dis. 30: 7–24
18. Li, K., M.L. Wahlqvist & D. Li. 2016. Nutrition, one-carbon metabolism and neural tube defects: a review. Nutrients 8. pii: E741
19. Wilde, J.J., J.R. Petersen & L. Niswander. 2014. Genetic, epigenetic, and environmental contributions to neural tube closure. Annu. Rev. Genet. 48: 583–611
20. Khoshnood, B., M. Loane, H. de Walle, et al. 2015. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ 351: h5949
21. WHO, UNICEF, UNFPA, et al. 2015. Trends in maternal mortality: 1990 to 2015. Accessed October 12, 2017. http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/en/
22. Stevens, G.A., L. Alkema, R.E. Black, et al. 2016. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet 388: e19–e23
23. Lo, A., D. Polsek & S. Sidhu. 2014. Estimating the burden of neural tube defects in low- and middle-income countries. J. Glob. Health 4: 010402
24. Zaganjor, I., A. Sekkarie, B.L. Tsang, et al. 2016. Describing the prevalence of neural tube defects worldwide: a systematic literature review. PLoS One 11: e0151586
25. Atta, C.A., K.M. Fiest, A.D. Frolkis, et al. 2016. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis. Am. J. Public Health 106: e24–e34
26. Hoy, D., P. Brooks, A. Woolf, et al. 2012. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J. Clin. Epidemiol. 65: 934–939
27. McDonnell, R., V. Delany, M.T. O'Mahony, et al. 2015. Neural tube defects in the Republic of Ireland in 2009–11. J. Public Health 37: 57–63
28. Blencowe, H., S. Moorthie, M. Darlinson, et al. 2017. Access to care and the effect of interventions on the outcomes of congenital disorders. J. Community Genet
29. UN Population Division. 2013. World abortion policies. Accessed November 2, 2017. http://www.un.org/en/development/desa/population/publications/pdf/policy/WorldAbortionPolicies2013/WorldAbortionPolicies2013_WallChart.pdf
30. UN Population Division. 2015. World population prospects: the 2015 revision. Accessed October 12, 2017. http://esa.un.org/wpp/index.htm
31. United Nations. Sustainable development goals regional groups. Accessed October 12, 2017. https://unstats.un.org/sdgs/indicators/regional-groups/
32. Food Fortification Initiative. Country profiles. Accessed October 12, 2017. http://www.ffinetwork.org/
33. Elwood, J.H. & N.C. Nevin. 1973. Anencephalus and spina bifida in Belfast (1964–1968). Ulster Med. J. 42: 213–222
34. Rickham, P.P. & T. Mawdsley. 1966. The effect of early operation on the survival of spina bifida cystica. Dev. Med. Child Neurol. 8(Suppl. 11): 20–26
35. Knox, E.G. 1967. Spina bifida in Birmingham. Dev. Med. Child Neurol. 9(Suppl. 13): 14–22
36. Laurence, K.M. & B.J. Tew. 1971. Natural history of spina bifida cystica and cranium bifidum cysticum. Major central nervous system malformations in South Wales. IV. Arch. Dis. Child. 46: 127–138
37. Warf, B.C., E.J. Wright & A.V. Kulkarni. 2011. Factors affecting survival of infants with myelomeningocele in southeastern Uganda. J. Neurosurg. Pediatr. 7: 127–133
38. Heazell, A.E., D. Siassakos, H. Blencowe, et al. 2016. Stillbirths: economic and psychosocial consequences. Lancet 387: 604–616
39. Rofail, D., L. Maguire, R. Heelis, et al. 2012. The impact of spina bifida on caregivers. Neurol. Ther. 1: 4
40. Rofail, D., L. Maguire, M. Kissner, et al. 2013. A review of the social, psychological, and economic burdens experienced by people with spina bifida and their caregivers. Neurol. Ther. 2: 1–12
41. Bowles, D., R. Wasiak, M. Kissner, et al. 2014. Economic burden of neural tube defects in Germany. Public Health 128: 274–281
42. Dicianno, B.E., N. Kinback, M.H. Bellin, et al. 2015. Depressive symptoms in adults with spina bifida. Rehabil. Psychol. 60: 246–253
43. Wagner, R., R. Linroth, C. Gangl, et al. 2015. Perception of secondary conditions in adults with spina bifida and impact on daily life. Disabil. Health J. 8: 492–498
44. Fischer, N., P. Church, J. Lyons, et al. 2015. A qualitative exploration of the experiences of children with spina bifida and their parents around incontinence and social participation. Child Care Health Dev. 41: 954–962
45. Yi, Y., M. Lindemann, A. Colligs, et al. 2011. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur. J. Pediatr. 170: 1391–1400
46. Mullan, Z. & R. Horton. 2011. Bringing stillbirths out of the shadows. Lancet 377: 1291–1292
47. Sayed, A.R., D. Bourne, R. Pattinson, et al. 2008. Decline in the prevalence of neural tube defects following folic acid fortification and its cost–benefit in South Africa. Birth Defects Res. A Clin. Mol. Teratol. 82: 211–216
48. De-Regil, L.M., A.C. Fernández-Gaxiola, T. Dowswell, et al. 2010. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst. Rev. CD007950
49. Wlodarczyk, B.J., A.M. Palacios, T.M. George, et al. 2012. Antiepileptic drugs and pregnancy outcomes. Am. J. Med. Genet. A 158A: 2071–2090
50. Simpamba, M.M., P.M. Struthers & M.M. Mweshi. 2016. Access to health care for children with neural tube defects: experiences of mothers in Zambia. Afr. J. Disabil. 5: 267
51. Rosenthal, J., M.E. Reeve, N. Ramirez, et al. 2016. Red blood cell folate insufficiency among nonpregnant women of childbearing age in Guatemala 2009 to 2010: prevalence and predicted neural tube defects risk. Birth Defects Res. A Clin. Mol. Teratol. 106: 587–595
52. Shah, I. & E. Ahman. 2009. Unsafe abortion: global and regional incidence, trends, consequences, and challenges. J. Obstet. Gynaecol. Can. 31: 1149–1158
53. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. 2016. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388: 1545–1602
54. Liu, L., S. Oza, D. Hogan, et al. 2017. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the sustainable development goals. Lancet 388: 3027–3035
55. World Health Organization. 2017. WHO mortality database. Accessed July 12, 2017. http://www.who.int/healthinfo/statistics/mortality_rawdata/en/